Discussing Agios’ Mitapivat (pyruvate kinase R activator) in Adult PK Deficiency following June 2022 Phase 3 ACTIVATE analysis

Scheduled for:Jul 30, 2022 8:00 PM EDT

Call Duration:30 minutes

Desired Expert

To understand the needs of PK Deficiency patients, the treatment protocols, and to assess Mitapivat’s potential.

Interview Goal

A genetician specialized in rare genetic disorders, with previous experience in treating Pyruvate Kinase Deficiencies.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.